Andrea Burnett-Hartman, PhD, MPH

Senior Investigator

Andrea Burnett-Hartman, PhD, MPH, is a Senior Investigator at the KP Colorado Institute for Health Research with strong experience in multi-site, collaborative research, including the National Institutes of Health sponsored Population-based Research to Optimize the Screening Process (PROSPR), the Cancer Research Network (CRN), and the Kaiser Permanente Research Bank (KPRB). Her research focuses on cancer epidemiology, screening, and prevention, as well as precision medicine approaches in cancer care. Dr. Burnett-Hartman also conducts research aimed at understanding and addressing health disparities in cancer screening and outcomes. Her research is motivated by the opportunity to contribute to the prevention of suffering through optimizing cancer prevention and treatment approaches and ensuring equity in care.

Dr. Burnett-Hartman received her Master of Public Health degree from the University of Michigan and completed her doctoral training in epidemiology at the University of Washington. While in Seattle, she completed her post-doctoral training at the Fred Hutchinson Cancer Research Center.

Dr. Burnett-Hartman is an Affiliate Instructor in the Department of Epidemiology at the University of Washington School of Public Health as well as an Affiliate Investigator at the Fred Hutchinson Cancer Research Center.

Selected Research:

  • A Cohort Study of Sessile Serrated Polyps and Subsequent Colorectal Neoplasia
  • Recent evidence implicates an additional group of polyps, sessile serrated polyps, as potential precursors to a subset of colorectal cancer. This project investigated the clinical significance of sessile serrated polyps, with the long-term goal of identifying new groups that are high-risk for colorectal cancer and improving the effectiveness of colorectal cancer screening.

    • Funder: National Cancer Institute
    • Award End Date: 03/31/2018

  • Center for Research to Optimize Precision Lung Cancer Screening in Diverse Populations (PROSPR II - Lung)
  • The long-term goal of this multi-site center grant is to identify critical gaps in the lung cancer screening process and to design innovative, multilevel interventions to reduce lung cancer mortality, particularly among underserved populations.

    • Funder: National Cancer Institute
    • Award End Date: 03/31/2023

  • PROSPR Coordinating Center (PCC)
  • The goal of the PROSPR Coordinating Center (PCC) is to coordinate the research of PROSPR Research Centers to achieve PROSPR's mission of evaluating and improving the cancer screening process (recruitment, screening, diagnosis, and referral for treatment).

    • Funder: National Cancer Institute
    • Award End Date: 03/31/2023

  • Serrated Colorectal Cancer: An Emerging Disease Subtype
  • The objective of this project is to characterize factors relating to the genetic predisposition, clinical presentation, and prognosis of serrated colorectal cancer.

    • Funder: National Cancer Institute
    • Award End Date: 04/30/2021

  • The Association Between Molecular Markers in Colorectal Sessile Serrated Polyps and Colorectal Cancer Risk
  • This project proposed to identify biomarkers in sessile serrated polyps that are associated with an increased risk of colorectal cancer. These biomarkers may later be used to guide colorectal cancer surveillance recommendations or included in stool-based DNA panels to improve the effectiveness of stool-based colorectal cancer screening tests.

    • Funder: Department of Defense
    • Award End Date: 07/31/2018

  • KP Precision Medicine Assessment and Response
  • The primary objective of this project was to identify attitudes, barriers, and facilitators to genetic testing and research participation among KP members.

    • Funder: Garfield Memorial Fund
    • Study End Date: 04/30/2019

  • Kaiser Permanente National Research Bank
  • The KP National Research Bank is a collaboration across all Kaiser regions nationally funded by Kaiser Foundation Health Plan. The goal of the KP National Research Bank is to collect blood samples from 500,000 adult KP members and utilize them, combined with survey data and medical information to create a state-of-the-art resource for genetic and health services research.

    • Funder: Kaiser Foundation Health Plan
    • Study End Date: 06/2021